- Federal agenciesImproved federal coordination could reduce duplicative epilepsy research and funding gaps.
- Federal agenciesA national plan and annual reporting may clarify research priorities and guide federal investment.
- Potential benefitEnhanced data sharing and surveillance could produce better epidemiology and targeted public‑health interventions.
National Plan for Epilepsy Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This bill creates a National Plan for Epilepsy within the Public Health Service Act to coordinate Federal research, prevention, diagnosis, treatment, and care for epilepsy. It requires an integrated plan, annual assessments, public reporting to Congress, and interagency data sharing.
Liberty/justice emphasis vs cost concerns: liberals prioritize equity; conservatives worry about cost
Noncontroversial health coordination bill with limited ideological hooks; funding questions could slow momentum.
This bill creates a National Plan for Epilepsy within the Public Health Service Act to coordinate Federal research, prevention, diagnosis, treatment, and care for epilepsy.
It requires an integrated plan, annual assessments, public reporting to Congress, and interagency data sharing.
The Secretary must establish an Advisory Council with Federal and non‑Federal members to meet quarterly and issue periodic reports.
Mostly technical public-health coordination with bipartisan appeal; absence of explicit funding and legislative calendar/priorities create uncertainty.
How solid the drafting looks.
Liberty/justice emphasis vs cost concerns: liberals prioritize equity; conservatives worry about cost
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesImplementing the plan will create new federal administrative costs not explicitly funded in the text.
- Potential burdenThe required reporting and coordination may increase regulatory or reporting burden on agencies and providers.
- Federal agenciesThe plan risks duplicating or overlapping existing NIH, CDC, and other federal epilepsy activities.
Why the argument around this bill splits.
Liberty/justice emphasis vs cost concerns: liberals prioritize equity; conservatives worry about cost
Likely broadly supportive because the bill prioritizes research, care coordination, and addressing disparities for people with epilepsy.
It is welcomed for mandating public reporting, patient representation, and attention to outcomes, but advocates will note the absence of dedicated appropriations.
Generally supportive of an organized federal approach to a noncontroversial health problem, but cautious about costs, duplication, and measurable outcomes.
Values the bill's sunset, reporting requirements, and interagency coordination while wanting clear implementation plans and cost estimates.
Cautiously receptive because it targets a specific health need and includes DoD and VA involvement, but wary of expanding federal bureaucracy and unfunded mandates.
Prefers limited scope, fiscal restraint, and emphasis on state and private-sector roles.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Mostly technical public-health coordination with bipartisan appeal; absence of explicit funding and legislative calendar/priorities create uncertainty.
- No explicit appropriation or cost estimate provided
- Potential agency resource constraints and implementation capacity
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberty/justice emphasis vs cost concerns: liberals prioritize equity; conservatives worry about cost
Mostly technical public-health coordination with bipartisan appeal; absence of explicit funding and legislative calendar/priorities create…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for National Plan for Epilepsy Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.